![]()
|
Report Date : |
16.08.2011 |
IDENTIFICATION DETAILS
|
Name : |
panbiotic laboratories |
|
|
|
|
Registered Office : |
NO.5-1, Dah Tong Rd., Niaosong Dist., Kaohsiung City 833 |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
15.06.1971 |
|
|
|
|
Com. Reg. No.: |
85615014 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacturing and sales of medicine |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 50,000 |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
Usually Correct |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Taiwan |
A2 |
A2 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
NO.5-1, Dah Tong
Rd., Niaosong Dist., Kaohsiung City 833, Taiwan (R.O.C.) |
|
Supplied Address: |
|
|
Telephone Number: |
|
|
Fax Number: |
|
Credit Rating: |
|
|
Credit Opinion: |
|
Registered Name: |
Panbiotic
Laboratories |
|
Registered Address: |
NO.5-1, Dah Tong
Rd., Niaosong Dist., Kaohsiung City 833, Taiwan (R.O.C.) |
|
Date of Foundation: |
|
|
Registration Number: |
|
|
Registry: |
Economic
Development Bureau of Kaohsiung City Government |
|
Registered Capital: |
NTD 281,151,110 (USD 9,727,828.406) (As of 2011.08,
1 NTD = 0.0346 USD) |
|
Paid-up Capital: |
NTD 281,151,110
(USD 9,727,828.406) |
|
Legal Representatives: |
|
|
Legal Form: |
|
|
Principal Activities: |
|
|
Staff: |
|
|
Listed at Stock
Exchange: |
|
|
Date of Last
Annual Return: |
Subject was incorporated on 1971-6-15 with registered
number 85615014 as Joint Stock Company in Taiwan.
Awards
|
Year |
Awards |
|
2007 |
Blue chip
importer and exporter |
|
2008 |
Blue chip
importer and exporter |
|
2009 |
Blue chip
importer and exporter |
Standard of Blue
chip importer and exporter
Unit: USD
|
Year |
Amount |
|
2007 |
18,000,000 |
|
2008 |
19,000,000 |
|
2009 |
15,000,000 |
|
Name |
Subscription Shares |
|
5,574,000 |
|
|
|
|
|
4,413,000 |
|
|
236,000 |
|
|
141,000 |
|
|
427,160 |
Core
Management
Directors
|
1 |
|
|
Name |
Kunshan Cai |
|
Position |
|
|
2 |
|
|
Name |
Fengji Cai |
|
Position |
Vice Board
Chairman |
|
3 |
|
|
Name |
Zengyi Yang |
|
Position |
|
|
4 |
|
|
Name |
Jinyi Zhan |
|
Position |
|
|
5 |
|
|
Name |
|
|
Position |
Director |
|
6 |
|
|
Name |
Wanyao Cai |
|
Position |
|
|
7 |
|
|
Name |
Shanhui Zhang |
|
Position |
Auditor |
Personnel
Structure
|
Total Employees |
More than 20 Employees |
Offices
& Factories
|
|
Headquarters |
|
Add |
NO.5-1, Dah Tong Rd., Niaosong Dist., Kaohsiung City 833, Taiwan
(R.O.C.) |
Production
Information
l
The subject produces medicine.
l
The subject produces in Taiwan.
Purchase
Information
l
The raw material for production is mostly
purchased from domestic markets and foreign markets.
l
The subject is mainly engaged in sales of medicine.
l
The subject sells medicines around the world.
Import and export
right:
|
Import right |
Yes |
|
Export right |
Yes |
Purchase
Domestic Purchase (Taiwan and Mainland, China)
|
Payment Terms |
Proportion |
|
|
COD, etc |
100% |
Foreign Purchase
|
Payment Terms |
Proportion |
|
|
CBD, etc |
100% |
Sales
Domestic Markets (Taiwan)
|
Sales Terms |
Proportion |
|
|
CBD, etc |
100% |
Export
|
Sales Terms |
Proportion |
|
|
Medicine |
CBD, etc |
100% |
|
Year |
Sales |
|
2010 |
About USD 4,000,000 |
|
Name |
Taiwan Bank |
Mortgage
No chattel mortgage record of subject has been found within the recent 3
months.
Lawsuit
Up to date of
reporting, no existing or latent litigation of the subject has been found.
|
Name |
Deshan Li |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.37 |
|
|
1 |
Rs.73.53 |
|
Euro |
1 |
Rs.64.36 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.